Sensient Technologies Cor... (SXT)
73.62
0.02 (0.03%)
At close: Mar 31, 2025, 11:00 AM
Sensient Technologies Corporation Revenue Breakdown
Quarter | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Dec 31, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Natural Ingredients Revenue | 143.07M | 74.29M | 68.29M | 178.74M | 66.3M | 57.16M | 52.42M | 51.22M | 56.74M | 58.14M | 56.2M | 53.2M |
Natural Ingredients Revenue Growth | +92.59% | +8.79% | -61.79% | +169.59% | +15.98% | +9.04% | +2.35% | -9.73% | -2.40% | +3.46% | +5.63% | n/a |
Personal Care Revenue | 80.63M | 43.2M | 42.97M | 118.54M | 37.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Personal Care Revenue Growth | +86.67% | +0.54% | -63.75% | +218.52% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Quarter | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asia Pacific Revenue | 238.72M | 221.67M | 711.1M | 658M | 614.3M | 575.2M | 213.03M | 208.94M | 196.88M | 177.56M | 193.16M | 191.34M | 199.85M | 190.4M |
Asia Pacific Revenue Growth | +7.69% | -68.83% | +8.07% | +7.11% | +6.80% | +170.01% | +1.96% | +6.12% | +10.88% | -8.08% | +0.95% | -4.26% | +4.96% | n/a |
Europe Revenue | 293.59M | 276.64M | 229.29M | 221.57M | 199.92M | 205.98M | 342.06M | 324.6M | 342.82M | 349.1M | 389.59M | 382.46M | 371.66M | 405.31M |
Europe Revenue Growth | +6.13% | +20.65% | +3.49% | +10.83% | -2.94% | -39.78% | +5.38% | -5.32% | -1.80% | -10.39% | +1.86% | +2.91% | -8.30% | n/a |
North America Revenue | 910.33M | 858.91M | 267.57M | 278.23M | 289.98M | 307.63M | 722.73M | 718.71M | 745.66M | 744.78M | 750.35M | 784.66M | 785.92M | 737.15M |
North America Revenue Growth | +5.99% | +221.00% | -3.83% | -4.05% | -5.74% | -57.43% | +0.56% | -3.61% | +0.12% | -0.74% | -4.37% | -0.16% | +6.62% | n/a |
United States Revenue | 761.2M | 707.1M | 846.02M | 787.11M | 733.33M | 700.1M | 586.2M | 574.5M | 595M | 592.9M | n/a | 592.6M | n/a | n/a |
United States Revenue Growth | +7.65% | -16.42% | +7.48% | +7.33% | +4.75% | +19.43% | +2.04% | -3.45% | +0.35% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Quarter | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 77.42M | 79.88M | 81.06M | 77.14M | 91.77M | 69.1M | 70.59M | 73.83M | 70.28M | 74.27M | 75.76M | 72.06M | 71.96M | 68.11M | 75.84M | 68.72M | 69.18M | 64.49M | 60.09M | 77.33M | 99.95M | 63.61M | 64.4M | 65.81M | 60.76M | 65.31M | 69.29M | 67.39M | 65.21M | 70.72M | 74.84M | 96.91M | 69.31M | 71.41M | 80.77M | 68.32M | 74.47M | 69.55M | 73.09M | 70.99M |
Selling, General, and Administrative Revenue Growth | -3.08% | -1.46% | +5.08% | -15.94% | +32.81% | -2.11% | -4.39% | +5.05% | -5.37% | -1.97% | +5.14% | +0.13% | +5.65% | -10.19% | +10.37% | -0.67% | +7.27% | +7.33% | -22.30% | -22.63% | +57.12% | -1.22% | -2.14% | +8.30% | -6.96% | -5.74% | +2.82% | +3.35% | -7.80% | -5.50% | -22.77% | +39.81% | -2.94% | -11.58% | +18.21% | -8.25% | +7.06% | -4.84% | +2.96% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | 48.1M | n/a | n/a | n/a | 42.2M | n/a | n/a | n/a | 34.3M | n/a | n/a | n/a | 38.5M | n/a | n/a | n/a | 40.1M | n/a | n/a | n/a | 43M | n/a | n/a | n/a | 40.9M | n/a | n/a | n/a | 40.9M | n/a | n/a | n/a | 35.1M | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |